BST is a designer and manufacturer of medical devices and procedures for handling adipose tissue targeting the liposuction and body sculpting market, the bariatric market; and the fat autograft and adipocyte-derived stem cell processing markets. It is a developing a revolutionary minimally invasive device which will allow laparoscopic removal of the deadly visceral fat WITHIN the abdominal cavity as a safer and cost-saving treatment of obesity, metabolic syndrome and type 2 diabetes mellitus that will NOT involve cutting into the bowel or stomach, rearranging the body's alimentary plumbing…
Sensiotec, a leading innovator in biosensor and digital health technology, has developed Virtual Medical Assistant® (VMA), an award-winning approach to patient care that can transform healthcare across the care continuum worldwide. VMA is a radar-based biosensing platform with a cloud-based monitoring solution that represents the world’s first FDA-cleared, truly non-contact, highly scalable, patient monitoring and preventive care system. From a sensor panel located under the patient’s bed or chair, VMA continuously streams actionable, real-time data, such as cardiorespiratory…
Stash is a technology company that has developed a patent-pending breakthrough of stunning impact in the cybersecurity realm – the solution to eradicating data vulnerability – a modern day scourge of immense proportion. An estimated 50+ Billion devices will be connected to each other by 2020 making for a nightmare of endpoints, each a way in to where your valuable data is, impossible to guard against intrusion, data theft, destruction, loss, and manipulation, as well as malware and ransomware. Unless you have Stash.99.9% of other security options are but tools, developed as fences, walls,…
Simulare Medical Corp. has recognized the global need for more effective surgical training tools and methods in both developed and developing countries. To address this need, Simulare develops and integrates innovative medical training programs with anatomically-accurate simulators to help trainee surgeons learn and perfect complex procedures in a safe environment. With our dedication to excellence, our collaboration with leading surgeons and medical education organizations in more than 20 countries, and our growing suite of training programs and simulators, Simulare’s goal is to be the…
CohBar, Inc. is an innovative biotechnology company whose mission is to treat major diseases and extend healthy life spans through the discovery of novel Mitochondrial-Derived Peptides (“MDPs”) and the advancement of their development into clinically relevant and commercially successful therapeutics.CohBar’s scientific leadership is centered on the expertise of our founders, Dr. Pinchas Cohen, Dean of the Davis School of Gerontology at the University of Southern California, and Dr. Nir Barzilai, Professor of Genetics and Director of the Institute for Aging Research at the Albert…
Breakthrough Medical Technology: Imaging3 has developed a breakthrough medical technology (patented) that will produce 3D medical diagnostic images in real time. Imaging3 Technology has enormous potential to contribute to the improvement of healthcare. Imagine for a moment a future healthcare center equipped with Imaging3 devices. For the first time ever, healthcare workers will be able to instantly view 3D, high- resolution images of virtually any part of the human body.Imaging3 Technology 3D images are instantly constructed using high- resolution fluoroscopy and can be used as real time…
RDD Pharma is a clinical stage company that is addressing an overlooked therapeutic area of lower gastrointestinal (GI) diseases. The company has two programs with a Phase 3 Ready molecule in Anal Fissure and an ongoing Phase 2a molecule in Fecal Incontinence. Both programs utilize an accelerated 505(b)2 regulatory path and address a meaningful, high, unmet medical need.RDD is privately held and VC backed (OrbiMed).
Inanovate began operations in 2007 with a mission to develop the best surface in the world for studying protein interactions. In 2008 the Company opened research and development facilities in Research Triangle Park, North Carolina and built a strong core team combining over 50 years of life science technology development expertise. This team was further strengthened through a network of advisors, consultants, collaborators and partners, from leading clinical and industrial organisations.In 2009 Inanovate completed development and testing of the i-Slide - a novel protein microarray…
Cadence is a communications, research and consulting firm focused on supporting our clients through greater awareness, knowledge and understanding of their markets. We offer services in three critical areas: market research, consulting and medical communications. Our innovative approach to project work leverage our capabilities across all three practice areas to drive efficiencies and deeper insights for all our clients.
CEO Sherrin Ingram chairs this high-performing Vistage CEO Peer Advisory Group. She can be reached at sherrin@sherrin.com or call 630-514-7743.
THE BIG PICTURE:With close to 20,000 members in 15 countries, Vistage International is the world’s leading chief executive leadership organization for good reason: Vistage works. Since 1957, Vistage has been providing unparalleled access to new ideas and fresh thinking through monthly peer meetings, one-on-one strategic planning sessions, speaker presentations from only the top industry experts, social networking and an extensive online content…
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We believe it should be easy for patients to contribute to the advancement of research for medical conditions that matter most to them, regardless of their location or ability to travel. Our mobile staff covers the US, Canada and parts of Europe. Each staff member is trained on study specific protocols and carries the credentials necessary to conduct clinical trial procedures in the patient's home.
Quantgene develops the first functional universal cancer screening test in the world. Our test uses blood samples to detect the 10 deadliest cancers at stage 1 and 2 before the tumor metastasizes. Our team spread across the world's leading institutions in cancer research, including UC Berkeley, Stanford University, Memorial Sloan Kettering Cancer Center and Geneva University Hospital, Switzerland.
ActX, Inc. is a dynamic venture that is focused on making patient genomic information truly useful in everyday medical practice. We focus on actionable genetic risks. Evidence based genetic risks that you can do something about, whether it is a medication affected by genetics, or a medical genetic risk such as a specific cancer risk. We are a team of talented geneticists, physicians, pharmacologists, genetic counselors, software developers and devops specialists.
JN-International Medical Corporation is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. JNIMC has overseas business offices and clinical trial centers located in Abidjan, Ivory Coast in Africa with vaccine cold chain facilities in Burkina Faso. JNIMC partners with Global Health Organizations such as the Clinton Global Initiative, the Global Business Coalition, New York President's Malaria Initiative and PEPFAR. JNI also partners with several other non-profit global health…
ResearchDx was founded on the core principles and expertise that help biopharmaceutical companies accelerate, develop and manufacture their companion diagnostic products. As the premier Contract Diagnostics Organization, ResearchDx has established integrated, turnkey, flexible services that are focused on our customer’s objectives. We manage the entire diagnostic development process from initial assay concept and discovery all the way through clinical research to regulatory approval. At ResearchDx we believe in bringing personalized medicine to the next level.
A2A is developing new drug candidates (NDC) for Lukemia, Pancreatic and Lung cancer. The NDCs are the product of sophisticated computer algorithms designed to optimize efficacy and safety across 10s of millions of potential molecules. Our objective is to prove that the NDCs are better than existing drugs and than partner with a major pharmaceutical company.
The Xcellent Life management team brings a combined 85 years of experience with leadership, deep domain expertise, and a passion for making a positive difference. These leaders have come together under a single purpose and shared mission to improve the quality of life for all by advancing healthcare. Under this mission, the Xcellent Life team proceeds guided by our values with great excitement and energy knowing that we are helping others. We are developing the Xcellent Life Cloud Platform to deliver Real-time Human Diagnostics (RtHD), which will revolutionize the industry by focusing an…
TotipotentRX Corporation is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We operate three distinct businesses to serve patients, physicians and partners: Therapeutics Division Contract Services Division Cell Manufacturing and Banking Division The company has developed 10 autologous 60-90 minute bedside treatments in the areas of cardiology, vascular, and orthopedic medicine. TotipotentRX announced the significant top line results of its Phase Ib (safety and efficacy) trial for no-option critical limb ischemia in…
